James D. Whiteaker

发表

The Resistome of Pseudomonas aeruginosa in Relationship to Phenotypic Susceptibility

Jacques Corbeil, Maxime Déraspe, Maxime Déraspe, 2014, Antimicrobial Agents and Chemotherapy.

Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.

J. Ambler, R. Alm, R. Mclaughlin, 2015, The Journal of antimicrobial chemotherapy.

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Christopher B. Cooper, Amit K. Gupta, D. Murray, 2017, Journal of medicinal chemistry.

Characterization of the Novel DNA Gyrase Inhibitor AZD0914: Low Resistance Potential and Lack of Cross-Resistance in Neisseria gonorrhoeae

M. Huband, R. Alm, R. Mclaughlin, 2014, Antimicrobial Agents and Chemotherapy.

Overexpression of Pseudomonas aeruginosa LpxC with its inhibitors in an acrB-deficient Escherichia coli strain.

S. McLeod, P. Ross, F. Reck, 2014, Protein expression and purification.

A Homogeneous, High-Throughput-Compatible, Fluorescence Intensity–Based Assay for UDP-N-Acetylenolpyruvylglucosamine Reductase (MurB) with Nanomolar Product Detection

James D. Whiteaker, Jian Huang, A. Shapiro, 2012, Journal of biomolecular screening.

Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.

R. Alm, R. Mclaughlin, James D. Whiteaker, 2015, The Journal of antimicrobial chemotherapy.

Small-Molecule Inhibitors of Gram-Negative Lipoprotein Trafficking Discovered by Phenotypic Screening

S. McLeod, R. Mclaughlin, James D. Whiteaker, 2015, Journal of bacteriology.

Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.

A. Narayan, V. Ramachandran, R. Mclaughlin, 2014, Journal of medicinal chemistry.

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

J. Mckinney, L. Chiarelli, N. Dhar, 2014, Journal of medicinal chemistry.

Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.

Vijay T. Ahuja, A. Srivastava, A. Narayan, 2013, Journal of medicinal chemistry.

Lead optimization of 1,4-azaindoles as antimycobacterial agents.

Christopher B. Cooper, S. Butler, A. Srivastava, 2014, Journal of medicinal chemistry.

Characterization of the novel DNA gyrase inhibitor AZD 0914 : Low resistance potential 1 and lack of cross-resistance in Neisseria gonorrhoeae . 2 3 4 5 6

M. Huband, R. Alm, James D. Whiteaker, 2014 .

Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of β-Lactam and Vancomycin Resistance in Enterococcus faecium

Mónica A. García-Solache, L. Rice, M. Gilmore, 2016, Antimicrobial Agents and Chemotherapy.

Small-Molecule Inhibitors of Gram-Negative Lipoprotein Trafficking Discovered by Phenotypic Screening

S. McLeod, R. Mclaughlin, James D. Whiteaker, 2015, Journal of bacteriology.

A High-Throughput Absorbance-Based Assay for Methionine Produced by Methionine Aminopeptidase Using S-Adenosyl-L-Methionine Synthetase

James D. Whiteaker, A. Shapiro, G. Walkup, 2011, Journal of biomolecular screening.